These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 34816620)

  • 1. Long noncoding RNAs to predict postoperative recurrence in bladder cancer and to develop a new molecular classification system.
    Li Z; Jiang L; Zhang Z; Deng M; Wei W; Tang H; Guo S; Ye Y; Yao K; Liu Z; Zhou F
    Cancer Med; 2022 Jan; 11(2):539-552. PubMed ID: 34816620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A robust signature of immune-related long non-coding RNA to predict the prognosis of bladder cancer.
    Lai C; Wu Z; Li Z; Yu H; Li K; Tang Z; Liu C; Xu K
    Cancer Med; 2021 Sep; 10(18):6534-6545. PubMed ID: 34374227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer.
    Song Y; Jin D; Chen J; Luo Z; Chen G; Yang Y; Liu X
    Aging (Albany NY); 2020 Jun; 12(12):12051-12073. PubMed ID: 32579540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 15-lncRNA-Based Classifier-Clinicopathologic Nomogram Improves the Prediction of Recurrence in Patients with Hepatocellular Carcinoma.
    Zhang Q; Ning G; Jiang H; Huang Y; Piao J; Chen Z; Tan X; Zhang J; Liu G
    Dis Markers; 2020; 2020():9180732. PubMed ID: 33520012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancer.
    Wang J; Shen C; Dong D; Zhong X; Wang Y; Yang X
    Int Immunopharmacol; 2021 Jan; 90():107146. PubMed ID: 33189610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Competing Endogenous RNA Network and an 8-lncRNA Prognostic Signature Identify
    Shen D; Zhang Y; Zheng Q; Yu S; Xia L; Cheng S; Li G
    DNA Cell Biol; 2021 Jan; 40(1):26-35. PubMed ID: 33270518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A hypoxia related long non-coding RNA signature could accurately predict survival outcomes in patients with bladder cancer.
    Zhang F; Wang X; Hu H; Yang Y; Wang J; Tang Y; Li D; Bai Y; Han P
    Bioengineered; 2021 Dec; 12(1):3802-3823. PubMed ID: 34281486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immune relevant signature for predicting prognoses and immunotherapeutic responses in patients with muscle-invasive bladder cancer (MIBC).
    Jiang W; Zhu D; Wang C; Zhu Y
    Cancer Med; 2020 Apr; 9(8):2774-2790. PubMed ID: 32096345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of five long noncoding RNAs signature and risk score for prognosis of bladder urothelial carcinoma.
    Zhang C; Li Z; Hu J; Qi F; Li X; Luo J
    J Cell Biochem; 2020 Jan; 121(1):856-866. PubMed ID: 31373406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
    Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
    Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer.
    Wu Y; Zhang L; He S; Guan B; He A; Yang K; Gong Y; Li X; Zhou L
    Aging (Albany NY); 2020 Nov; 12(22):23306-23325. PubMed ID: 33221763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y; Wang H; Huang Q; Wu J; Zhang M
    J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prognostic index based on a fourteen long non-coding RNA signature to predict the recurrence-free survival for muscle-invasive bladder cancer patients.
    Zhang X; Zhang M; Zhang X; Zhu X; Wang J
    BMC Med Inform Decis Mak; 2020 Jul; 20(Suppl 3):136. PubMed ID: 32646427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Long Non-coding RNA Markers for Prognostic Prediction of Patients with Bladder Cancer.
    Li WX; Zhang YL
    Chin Med Sci J; 2020 Sep; 35(3):239-247. PubMed ID: 32972501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinoma.
    Bao Z; Zhang W; Dong D
    Oncotarget; 2017 Feb; 8(6):10485-10497. PubMed ID: 28060759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis.
    de Jong JJ; Liu Y; Robertson AG; Seiler R; Groeneveld CS; van der Heijden MS; Wright JL; Douglas J; Dall'Era M; Crabb SJ; van Rhijn BWG; van Kessel KEM; Davicioni E; Castro MAA; Lotan Y; Zwarthoff EC; Black PC; Boormans JL; Gibb EA
    Genome Med; 2019 Oct; 11(1):60. PubMed ID: 31619281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 5-lncRNA Signature Associated with Smoking Predicts the Overall Survival of Patients with Muscle-Invasive Bladder Cancer.
    Sheng H; Zhang G; Huang Y; Sun L; Shi G; Ye D
    Dis Markers; 2021; 2021():8839747. PubMed ID: 33688381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.